Beyond CoCl₂: Toward decision-grade hypoxia modeling in gastric cancer histobiology

Hypoxia is a characteristic, although heterogeneous, of solid tumors, and experimental hypoxia is still far too frequently addressed as a single replaceable phenomenon. Yashiro et al. demonstrate in their recent article in Acta Histochemica that the signaling of lysophosphatidic acid receptor in gastric cancer cells differs significantly in cobalt chloride-induced but not physiological hypoxia with resulting differences in motility and cisplatin response. It is not an observation merely at the receptor level but it reveals a deeper reproducibility and translational issue in tumor biology. Pathway attribution, interpretation of drug-response and prioritization of targets can be misleading when chemical hypoxia is to be used as a surrogate to oxygen deprivation without explicit validation. We believe that this paper must motivate the field-wide to abandon convenience-driven hypoxia modelling in favour of decision-grade hypoxia phenotyping. There should be future work to incorporate physiologically accurate oxygen control, orthogonal confirmation of hypoxic conditions, spatially resolved histochemical reporters and standard reporting of receptor-context interactions. This framework would enhance mechanistic accuracy, enhance cross-study comparability, and expedite translation of hypoxia-informed therapeutic interventions in gastric cancer and other diseases.